Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6780a (MIR6780A) is a non-coding RNA molecule classified as a microRNA (miRNA) and is involved in post-transcriptional regulation of gene expression by binding to target mRNA sequences, leading to their degradation or translational inhibition[4][2]. There is little evidence from current literature and recognized genetic databases indicating that "microRNA 6780a" (MIR6780A) itself is a well-established, functionally studied, or clinically recognized miRNA in humans. MicroRNAs are short (~22 nucleotide) non-coding RNA molecules that regulate gene expression by binding to complementary sequences on target messenger RNA transcripts, thus silencing or degrading them[4][2]. The canonical biogenesis of a microRNA involves processing of a primary transcript (pri-miRNA) by DROSHA and DICER enzymes, yielding mature miRNA that integrates into the RNA-induced silencing complex (RISC) and guides it to target mRNAs[2]. MicroRNAs are crucial in many biological processes such as cell differentiation, proliferation, apoptosis, and cancer biology[1][3][5]. The specific molecule "microRNA 6780a" (MIR6780A), with aliases including "hsa-mir-6780a," appears to follow standard miRNA naming conventions, but there is no significant published evidence of its functional characterization, disease association, or therapeutic targeting as of late 2025. In general, miRNAs may play roles in cancer, immune regulation, and development, but there is no indication that microRNA 6780a itself meets criteria as a recognized therapeutic target, biomarker, or mechanistically significant molecule[1][4][3]. Notable limitation: - The information on "microRNA 6780a" (MIR6780A) is not supported by well-indexed genomic, pharmacological, or disease databases at this time. The entry may be misspelled, hypothetical, not curated in major reference sources, or reflect a molecule not yet characterized in peer-reviewed literature. If you need details for a different or well-characterized microRNA, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6780a (MIR6780A).